Study of cerebrospinal fluid shunt-associated infections in the first year following placement, by the Canadian Nosocomial Infection Surveillance Program

Infection Control and Hospital Epidemiology

Volumn 30, Issue 3, 2009, Pages 285-288

  Langley, Joanne M ^a,b   Gravel, Denise ^c   Moore, Dorothy ^e   Matlow, Anne ^d   Embree, Joanne ^f,i   MacKinnon Cameron, Donna ^b   Conly, John ^g   Bryce, E ^h   Embil, J ^f   Forgie, S ⁱ   Gardam, M ^j   Gaudreau, M ^k   Gravel, D ^c   Henderson, E ^l   Hutchinson, J ^m   John, M ⁿ   Kuhn, M ^o   Matlow, A ^d   Moore, D ^e   Mulvey, M ^p   Ofner Agostini, M ^c   Paton, S ^c   Roth, V ^q   Simor, A ^r   Stegenga, J ^c   Taylor, G ^s   Vearncombe, M ^r   Wong, A ^t   Zoutman, D ^u   more..

^a DALHOUSIE UNIVERSITY   (Canada)

^b IWK HEALTH CENTRE   (Canada)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e MONTREAL CHILDREN S HOSPITAL   (Canada)

^f HEALTH SCIENCES CENTRE   (Canada)

^g UNIVERSITY OF CALGARY   (Canada)

^h VANCOUVER GENERAL HOSPITAL   (Canada)

ⁱ STOLLERY CHILDREN S HOSPITAL   (Canada)

^j UNIVERSITY HEALTH NETWORK   (Canada)

^k LAVAL UNIVERSITY   (Canada)

^l Peter Lougheed Centre   (Canada)

^m Health Sciences Centre St John's   (Canada)

ⁿ LONDON HEALTH SCIENCES CENTRE   (Canada)

^o MONCTON HOSPITAL   (Canada)

^p PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^q UNIVERSITY OF OTTAWA   (Canada)

^r SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^s UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^t ROYAL UNIVERSITY HOSPITAL   (Canada)

^u KINGSTON GENERAL HOSPITAL   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN; CLOXACILLIN; RIFAMPICIN; VANCOMYCIN;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CEREBROSPINAL FLUID SHUNTING; CHILD; FEMALE; GROUPS BY AGE; HEALTH CENTER; HEALTH SURVEY; HOSPITAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE INFECTION;

EID: 61849098801     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/593969     Document Type: Article

References (10)

1. Patwardhan RV, Nanda A. Implanted ventricular shunts in the United States: the billion-dollar-a-year cost of hydrocephalus treatment. Neurosurgery 2005; 56:139-144.
2. Schoenbaum SC, Gardner P, Shillito J. Infections of cerebrospinal fluid shunts: epidemiology, clinical manifestations, and therapy. J Infect Dis 1975; 131:543-552.
3. McLone D, Czyzewski D, Raimondi A, Sommers R. Central nervous system infections as a limiting factor in the intelligence of children with myelomeningocoele. Pediatrics 1982; 70:338-342.
4. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32:470-485.
5. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992; 13:606-608.
6. Thompson DN, Hartley JC, Hayward RD. Shunt infection: is there a near-miss scenario? J Neurosurg 2007; 106(1 Suppl):15-19.
7. Choux M, Genitori L, Lang D, Lena G. Shunt implantation: reducing the incidence of shunt infection. J Neurosurg 1992; 77:875-880.
8. Mottolese C, Grando J, Convert J, et al. Zero rate of shunt infection in the first postoperative year in children - dream or reality? Childs Nerv Syst 2000; 16:210-212.
9. Ratilal B, Costa J, Sampaio C. Antibiotic prophylaxis for surgical introduction of intracranial ventricular shunts: a systematic review. J Neurosurg Pediatrics 2008; 1:48-56.
10. Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Am J Surg 2005; 189:395-404.